1. Home
  2. SKWD vs AVDL Comparison

SKWD vs AVDL Comparison

Compare SKWD & AVDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Skyward Specialty Insurance Group Inc.

SKWD

Skyward Specialty Insurance Group Inc.

HOLD

Current Price

$51.16

Market Cap

2.3B

Sector

Finance

ML Signal

HOLD

Logo Avadel Pharmaceuticals plc

AVDL

Avadel Pharmaceuticals plc

HOLD

Current Price

$21.56

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SKWD
AVDL
Founded
2007
2015
Country
United States
Ireland
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
2.1B
IPO Year
2023
1996

Fundamental Metrics

Financial Performance
Metric
SKWD
AVDL
Price
$51.16
$21.56
Analyst Decision
Buy
Buy
Analyst Count
12
9
Target Price
$65.30
$18.38
AVG Volume (30 Days)
322.9K
1.6M
Earning Date
10-29-2025
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
3.25
N/A
EPS
3.37
N/A
Revenue
$1,335,358,000.00
$248,517,000.00
Revenue This Year
$24.24
$65.47
Revenue Next Year
$30.16
$30.88
P/E Ratio
$15.34
N/A
Revenue Growth
22.27
79.88
52 Week Low
$41.28
$6.38
52 Week High
$65.05
$23.57

Technical Indicators

Market Signals
Indicator
SKWD
AVDL
Relative Strength Index (RSI) 58.74 59.83
Support Level $51.50 $21.50
Resistance Level $52.29 $21.60
Average True Range (ATR) 1.29 0.12
MACD 0.15 -0.09
Stochastic Oscillator 67.71 63.24

Price Performance

Historical Comparison
SKWD
AVDL

About SKWD Skyward Specialty Insurance Group Inc.

Skyward Specialty Insurance Group Inc is a specialty insurance company that delivers commercial property and casualty products and solutions on a non-admitted and admitted basis. The firm has one reportable segment through which it offers a broad array of insurance coverages to several market niches. It operates multiple lines of business, including general liability, excess liability, professional liability, commercial auto, group accident, health, property, surety, and workers' compensation.

About AVDL Avadel Pharmaceuticals plc

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.

Share on Social Networks: